{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:00:32Z","timestamp":1787166032346,"version":"build-2736575974"},"reference-count":103,"publisher":"Wiley","issue":"7-8","license":[{"start":{"date-parts":[[2012,2,28]],"date-time":"2012-02-28T00:00:00Z","timestamp":1330387200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Drug Testing and Analysis"],"published-print":{"date-parts":[[2012,7]]},"abstract":"<jats:p>Three indole alkaloids that possess differing degrees of psychotropic\/psychedelic activity have been reported as endogenous substances in humans; N,N\u2010dimethyltryptamine (DMT), 5\u2010hydroxy\u2010DMT (bufotenine, HDMT), and 5\u2010methoxy\u2010DMT (MDMT). We have undertaken a critical review of 69 published studies reporting the detection or detection and quantitation of these compounds in human body fluids. In reviewing this literature, we address the methods applied and the criteria used in the determination of the presence of DMT, MDMT, and HDMT. The review provides a historical perspective of the research conducted from 1955 to 2010, summarizing the findings for the individual compounds in blood, urine, and\/or cerebrospinal fluid. A critique of the data is offered that addresses the strengths and weaknesses of the methods and approaches to date. The review also discusses the shortcomings of the existing data in light of more recent findings and how these may be overcome. Suggestions for the future directions of endogenous psychedelics research are offered. Copyright \u00a9 2012 John Wiley &amp; Sons, Ltd.<\/jats:p>","DOI":"10.1002\/dta.422","type":"journal-article","created":{"date-parts":[[2012,2,28]],"date-time":"2012-02-28T02:34:40Z","timestamp":1330396480000},"page":"617-635","source":"Crossref","is-referenced-by-count":126,"title":["A critical review of reports of endogenous psychedelic N, N\u2010dimethyltryptamines in humans: 1955\u20132010"],"prefix":"10.1002","volume":"4","author":[{"given":"Steven A.","family":"Barker","sequence":"first","affiliation":[{"name":"School of Veterinary Medicine Louisiana State University  Baton Rouge LA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ethan H.","family":"McIlhenny","sequence":"additional","affiliation":[{"name":"School of Veterinary Medicine Louisiana State University  Baton Rouge LA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rick","family":"Strassman","sequence":"additional","affiliation":[{"name":"School of Medicine, University of New Mexico Albuquerque, and Cottonwood Research Foundation  Taos New Mexico USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2012,2,28]]},"reference":[{"key":"e_1_2_5_2_1","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0021-9258(18)71098-3","article-title":"Serotonin and its methylated derivatives in human urine","volume":"212","author":"Bumpus F.M.","year":"1955","journal-title":"J. Biol. Chem."},{"key":"e_1_2_5_3_1","first-page":"621","article-title":"Separation and characterization of urinary indoles resembling 5\u2010hydroxytryptamine and tryptamine","volume":"64","author":"Rodnight R.","year":"1956","journal-title":"Biochem."},{"key":"e_1_2_5_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(61)90220-3"},{"key":"e_1_2_5_5_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005053-196111000-00009"},{"key":"e_1_2_5_6_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1961.01710150028005"},{"key":"e_1_2_5_7_1","first-page":"576","article-title":"Urinary excretion of amines in normal children","volume":"30","author":"Perry T.L.","year":"1962","journal-title":"Pediatrics"},{"key":"e_1_2_5_8_1","first-page":"14","article-title":"Urinary excretion of bufotenin\u2010like substance in psychotic patients","volume":"4","author":"Brune G.G.","year":"1963","journal-title":"J. Neuropsychiatry"},{"key":"e_1_2_5_9_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.139.3555.587"},{"key":"e_1_2_5_10_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005053-196309000-00005"},{"key":"e_1_2_5_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9673(01)83697-9"},{"key":"e_1_2_5_12_1","doi-asserted-by":"publisher","DOI":"10.1038\/2061052a0"},{"key":"e_1_2_5_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/0022-3956(65)90030-0"},{"key":"e_1_2_5_14_1","doi-asserted-by":"publisher","DOI":"10.1038\/206963b0"},{"key":"e_1_2_5_15_1","doi-asserted-by":"publisher","DOI":"10.1038\/2071199b0"},{"key":"e_1_2_5_16_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005053-196605000-00011"},{"key":"e_1_2_5_17_1","doi-asserted-by":"publisher","DOI":"10.1038\/212146a0"},{"key":"e_1_2_5_18_1","first-page":"193","article-title":"Influence of treatment with an amine oxidase inhibitor on the excretion of bufotenin and the clinical symptoms in chronic schizophrenic patients","volume":"2","author":"Heller B.","year":"1966","journal-title":"Int. J. Neuropsychiat."},{"key":"e_1_2_5_19_1","first-page":"226","article-title":"Determination of bufotenin in the urine of schizophrenics","volume":"3","author":"Fischer E.","year":"1967","journal-title":"Int. J. Neuropsychiat."},{"key":"e_1_2_5_20_1","doi-asserted-by":"publisher","DOI":"10.1038\/2161110a0"},{"key":"e_1_2_5_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9673(00)84125-4"},{"key":"e_1_2_5_22_1","doi-asserted-by":"publisher","DOI":"10.1038\/216490a0"},{"key":"e_1_2_5_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(67)90138-5"},{"key":"e_1_2_5_24_1","first-page":"472","article-title":"Effect of trifluperidol (R 2498) on the urinary elimination of bufotenin in schizophrenia","volume":"3","author":"Acebal E.M.","year":"1967","journal-title":"Int. J. Neuropsychiat."},{"key":"e_1_2_5_25_1","doi-asserted-by":"publisher","DOI":"10.1038\/220489a0"},{"key":"e_1_2_5_26_1","first-page":"29","article-title":"Studies on the elimination of bufotenin in urine","volume":"1","author":"Sireix D.W.","year":"1969","journal-title":"Behav. Neuropsychiatry"},{"key":"e_1_2_5_27_1","first-page":"25","article-title":"Laboratory and animal studies on the chemistry of bufotenin. Quantitative determination on bufotenin in human urine","volume":"1","author":"Spatz H.","year":"1969","journal-title":"Behav. Neuropsychiatry"},{"key":"e_1_2_5_28_1","first-page":"235","article-title":"Studies on urinary elimination of bufotenin\u2010like substances in schizophrenia","volume":"2","author":"Fischer E.","year":"1970","journal-title":"Biol. Psychiat."},{"key":"e_1_2_5_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0033-3182(70)71667-8"},{"key":"e_1_2_5_30_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.117.539.421"},{"key":"e_1_2_5_31_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01898472"},{"key":"e_1_2_5_32_1","first-page":"9","article-title":"Urinary studies of schizophrenics and controls","volume":"3","author":"Narasimhachari N.","year":"1971","journal-title":"Biol. Psychiat."},{"key":"e_1_2_5_33_1","first-page":"21","article-title":"N,N\u2010Dimethylated indoleamines in blood","volume":"3","author":"Narasimhachari N.","year":"1971","journal-title":"Biol. Psychiat."},{"key":"e_1_2_5_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0033-3182(71)71520-5"},{"key":"e_1_2_5_35_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01537565"},{"key":"e_1_2_5_36_1","first-page":"311","article-title":"Studies of drug free schizophrenics and controls","volume":"5","author":"Narasimhachari N.","year":"1972","journal-title":"Biol. Psychiat."},{"key":"e_1_2_5_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2944(73)90014-8"},{"key":"e_1_2_5_38_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00422516"},{"key":"e_1_2_5_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-291X(73)80003-8"},{"key":"e_1_2_5_40_1","first-page":"89","article-title":"Blood dimethyltryptamine concentrations in psychotic disorders","volume":"9","author":"Lipinski J.F.","year":"1974","journal-title":"Biol. Psychiat."},{"key":"e_1_2_5_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(74)92455-6"},{"key":"e_1_2_5_42_1","first-page":"293","article-title":"Gas chromatographic\u2010mass spectrometric identification of urinary bufotenin and dimethyltryptamine in drug\u2010free chronic schizophrenic patients","volume":"8","author":"Narasimhachari N.","year":"1974","journal-title":"Biol. Psychiat."},{"key":"e_1_2_5_43_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.132.10.1067"},{"key":"e_1_2_5_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2944(75)90036-8"},{"key":"e_1_2_5_45_1","first-page":"425","article-title":"Biochemical studies in early infantile autism","volume":"10","author":"Narasimhachari N.","year":"1975","journal-title":"Biol. Psychiat."},{"key":"e_1_2_5_46_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00428697"},{"key":"e_1_2_5_47_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291700018304"},{"key":"e_1_2_5_48_1","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1177\/003591577606901122","article-title":"The excretion of dimethyltryptamine in psychiatric patients","volume":"69","author":"Murray R.M.","year":"1976","journal-title":"Proc. Royal Soc. Med."},{"key":"e_1_2_5_49_1","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1177\/070674377602100808","article-title":"Urinary excretion of N, N\u2010dimethylated tryptamines in chronic schizophrenia. A review of the present status of the hypothesis","volume":"21","author":"Huszka L.","year":"1976","journal-title":"Can. Psychiatr. Assoc. J."},{"key":"e_1_2_5_50_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.134.3.322"},{"key":"e_1_2_5_51_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00426775"},{"key":"e_1_2_5_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2944(77)90077-1"},{"key":"e_1_2_5_53_1","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S0022-3565(25)31309-1","article-title":"Determination of N,N\u2010dimethylindolealkylamines in plasma, blood and urine extracts by radioimmunoassay and high pressure liquid chromatography","volume":"206","author":"Riceberg L.J.","year":"1978","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"e_1_2_5_54_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.132.2.139"},{"key":"e_1_2_5_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-4347(00)81833-2"},{"key":"e_1_2_5_56_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1979.01780060034003"},{"key":"e_1_2_5_57_1","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1176\/ajp.1979.136.4a.439","article-title":"Urinary excretion of dimethyltryptamine in liver disease","volume":"136","author":"Checkley S.A.","year":"1979","journal-title":"Am. J. Psychiatr."},{"key":"e_1_2_5_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-4347(00)81837-X"},{"key":"e_1_2_5_59_1","first-page":"549","article-title":"Identification of dimethyltryptamine and O\u2010methylbufotenin in human cerebrospinal fluid by combined gas chromatography\/mass spectrometry","volume":"14","author":"Smythies J.R.","year":"1979","journal-title":"Biol. Psychiat."},{"key":"e_1_2_5_60_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.137.3.236"},{"key":"e_1_2_5_61_1","first-page":"1343","article-title":"Methylierte und nichtmethylierte indolamine in zisternalen liquor bei akuten endoenen psychosen","volume":"42","author":"Uebelhack R.","year":"1983","journal-title":"Biomed. Biochim. Acta"},{"key":"e_1_2_5_62_1","doi-asserted-by":"publisher","DOI":"10.1016\/0003-2697(83)90337-8"},{"key":"e_1_2_5_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(84)91263-7"},{"key":"e_1_2_5_64_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-3223(88)90182-5"},{"key":"e_1_2_5_65_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-3223(92)90066-9"},{"key":"e_1_2_5_66_1","doi-asserted-by":"publisher","DOI":"10.1016\/0165-1781(95)02747-K"},{"key":"e_1_2_5_67_1","doi-asserted-by":"publisher","DOI":"10.1097\/00001756-199511270-00024"},{"key":"e_1_2_5_68_1","doi-asserted-by":"publisher","DOI":"10.1080\/003655101753218319"},{"key":"e_1_2_5_69_1","doi-asserted-by":"publisher","DOI":"10.1080\/00365510510013604"},{"key":"e_1_2_5_70_1","first-page":"117","article-title":"Elevated urine levels of bufotenine in patients with autistic spectrum disorders and schizophrenia","volume":"31","author":"Emanuele E.","year":"2010","journal-title":"Neuro Endocrinol. Lett."},{"key":"e_1_2_5_71_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1166127"},{"key":"e_1_2_5_72_1","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.261pe12"},{"key":"e_1_2_5_73_1","volume-title":"DMT: The Spirit Molecule: A Doctor's Revolutionary Research into the Biology of Near\u2010Death and Mystical Experiences","author":"Strassman R.","year":"2001"},{"key":"e_1_2_5_74_1","doi-asserted-by":"publisher","DOI":"10.1080\/02791072.2005.10399803"},{"key":"e_1_2_5_75_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2006.11.001"},{"key":"e_1_2_5_76_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2004.03.002"},{"key":"e_1_2_5_77_1","doi-asserted-by":"publisher","DOI":"10.1080\/02791072.1991.10472572"},{"key":"e_1_2_5_78_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1994.03950020009001"},{"key":"e_1_2_5_79_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1994.03950020022002"},{"key":"e_1_2_5_80_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-3223(95)00200-6"},{"key":"e_1_2_5_81_1","doi-asserted-by":"publisher","DOI":"10.1016\/0166-4328(96)00081-2"},{"key":"e_1_2_5_82_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2005-916185"},{"key":"e_1_2_5_83_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881109103227"},{"key":"e_1_2_5_84_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.103.049882"},{"key":"e_1_2_5_85_1","doi-asserted-by":"publisher","DOI":"10.1159\/000077946"},{"key":"e_1_2_5_86_1","first-page":"201","article-title":"DMT at fifty","volume":"9","author":"Szara S.","year":"2007","journal-title":"Neuropsychopharmacol. Hungar."},{"key":"e_1_2_5_87_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.forsciint.2008.03.013"},{"key":"e_1_2_5_88_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(80)90169-0"},{"key":"e_1_2_5_89_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0074-7742(08)60291-3"},{"key":"e_1_2_5_90_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(87)90159-6"},{"key":"e_1_2_5_91_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(87)90118-3"},{"key":"e_1_2_5_92_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-3223(90)90566-K"},{"key":"e_1_2_5_93_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.98.411.309"},{"key":"e_1_2_5_94_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.133.2.203"},{"key":"e_1_2_5_95_1","first-page":"12","article-title":"Evidence for and against the involvement of N,N\u2010dimethyl\u2010 tryptamine (DMT) and 5\u2010methoxy\u2010N,N\u2010dimethyltryptamine (5\u2010MeO\u2010DMT) in schizophrenia","volume":"12","author":"Gillin J.C.","year":"1976","journal-title":"Psychopharmacol. Bull."},{"key":"e_1_2_5_96_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.134.3475.343"},{"key":"e_1_2_5_97_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.273.51.34502"},{"key":"e_1_2_5_98_1","doi-asserted-by":"publisher","DOI":"10.1006\/geno.1999.5960"},{"key":"e_1_2_5_99_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00702-009-0308-8"},{"key":"e_1_2_5_100_1","first-page":"840.19","article-title":"Indolethylamine N\u2010 methyltransferase expression in primate nervous tissue","volume":"37","author":"Cozzi N.V.","year":"2011","journal-title":"Soc. Neurosci. Abs."},{"key":"e_1_2_5_101_1","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(76)90441-0"},{"key":"e_1_2_5_102_1","doi-asserted-by":"publisher","DOI":"10.2174\/138920010794233495"},{"key":"e_1_2_5_103_1","doi-asserted-by":"publisher","DOI":"10.1002\/bmc.1657"},{"key":"e_1_2_5_104_1","doi-asserted-by":"publisher","DOI":"10.1002\/bmc.1551"}],"container-title":["Drug Testing and Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fdta.422","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/analyticalsciencejournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/dta.422","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T18:18:53Z","timestamp":1760379533000},"score":1,"resource":{"primary":{"URL":"https:\/\/analyticalsciencejournals.onlinelibrary.wiley.com\/doi\/10.1002\/dta.422"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2,28]]},"references-count":103,"journal-issue":{"issue":"7-8","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["10.1002\/dta.422"],"URL":"https:\/\/doi.org\/10.1002\/dta.422","archive":["Portico"],"relation":{},"ISSN":["1942-7603","1942-7611"],"issn-type":[{"value":"1942-7603","type":"print"},{"value":"1942-7611","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,2,28]]}}}